Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor
- PMID: 1701568
- DOI: 10.1126/science.1701568
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor
Erratum in
- Science 1991 Jan 25;251(4992):362
Abstract
A series of dipyridodiazepinones have been shown to be potent inhibitors of human immunodeficiency virus-1 (HIV-1) reverse transcriptase (RT). One compound, BI-RG-587, had a Ki of 200 nanomolar for inhibition of HIV-1 RT that was noncompetitive with respect to deoxyguanosine triphosphate. BI-RG-587 was specific for HIV-1 RT, having no effect on feline and simian RT or any mammalian DNA polymerases. BI-RG-587 inhibited HIV-1 replication in vitro as demonstrated by in situ hybridization, inhibition of protein p24 production, and the lack of syncytia formation in cultured human T cell lines and freshly isolated human peripheral blood lymphocytes. Cytotoxicity studies of BI-RG-587 on human cells showed a high therapeutic index (greater than 8000) in culture.
Similar articles
-
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.J Infect Dis. 1991 May;163(5):966-70. doi: 10.1093/infdis/163.5.966. J Infect Dis. 1991. PMID: 1708400
-
HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.Biochem Pharmacol. 1992 Mar 17;43(6):1371-6. doi: 10.1016/0006-2952(92)90515-k. Biochem Pharmacol. 1992. PMID: 1373283
-
BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.Antimicrob Agents Chemother. 1991 Feb;35(2):305-8. doi: 10.1128/AAC.35.2.305. Antimicrob Agents Chemother. 1991. PMID: 1708976 Free PMC article.
-
Inhibition of HIV-1 reverse transcriptase and virus replication by a non-nucleoside dipyridodiazepinone BI-RG-587 (Nevirapine).Med Res Rev. 1992 Jan;12(1):27-40. doi: 10.1002/med.2610120103. Med Res Rev. 1992. PMID: 1371177 Review. No abstract available.
-
The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors.Arch Virol Suppl. 1994;9:11-7. doi: 10.1007/978-3-7091-9326-6_2. Arch Virol Suppl. 1994. PMID: 7518271 Review.
Cited by
-
Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.Nucleic Acids Res. 2004 Jan 22;32(2):422-31. doi: 10.1093/nar/gkh160. Print 2004. Nucleic Acids Res. 2004. PMID: 14739234 Free PMC article.
-
Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers.Biochemistry. 2010 Jan 26;49(3):601-10. doi: 10.1021/bi901579y. Biochemistry. 2010. PMID: 20039714 Free PMC article.
-
Diversity-oriented solid-phase synthesis and biological evaluation of oligonucleotide hairpins as HIV-1 RT RNase H inhibitors.Nucleic Acids Res. 2004 Nov 29;32(21):6164-75. doi: 10.1093/nar/gkh948. Print 2004. Nucleic Acids Res. 2004. PMID: 15570067 Free PMC article.
-
Xenotropic murine leukemia virus-related virus is susceptible to AZT.Virology. 2010 Feb 5;397(1):1-6. doi: 10.1016/j.virol.2009.11.013. Epub 2009 Dec 2. Virology. 2010. PMID: 19959199 Free PMC article.
-
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10548-53. doi: 10.1073/pnas.0404151101. Epub 2004 Jul 12. Proc Natl Acad Sci U S A. 2004. PMID: 15249669 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources